Current Prices from Alpha Tau Medical Ltd. - Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	DRTS	USD	12.06.2025 23:32	3,08 USD	3,07 USD +0,33 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	1,82 %	10,00 %	16,89 %	0,33 %	32,19 %	-69,50 %

Company Profile for Alpha Tau Medical Ltd. - Ordinary Shares Share

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Company Data

Name Alpha Tau Medical Ltd. - Ordinary Shares

Company Alpha Tau Medical Ltd.

Symbol DRTS

Website https://www.alphatau.com

Primary Exchange

NASDAQ

ISIN IL0011839383

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Uzi Sofer

Market Capitalization 179 Mio

Country Israel

Currency USD

Employees 0,1 T

Address 5 Kiryat Hamada Street, 9777605 Jerusalem

IPO Date 2021-03-08

Ticker Symbols

Name	Symbol
NASDAQ	DRTS

More Shares

Investors who Alpha Tau Medical Ltd. - Ordinary Shares hold also have the following shares in their portfolio:

SEB SUST.H.YLD D (EUR) Fund

TEXHONG TEXTILE GRP Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog